ABSTRACT
The neurological changes associated with COVID-19 have been frequently described, especially in cases of greater severity, and are related to multifactorial causes, such as endothelial dysfunction, inflammatory mediator release (cytokine storm), endothelial dysfunction and hypoxemia. We report the case of a female patient, 88 years old, with cerebral hemorrhage associated with amyloid angiopathy in the context of SARS-CoV-2 infection.
Keywords:
Cerebral amyloid angiopathy; COVID-19; Coronavirus infections; SARS-CoV-2; Cerebral hemorrhage; Critical care; Intensive care units